Lynn Vitale‐Cross

2.3k total citations
22 papers, 1.5k citations indexed

About

Lynn Vitale‐Cross is a scholar working on Molecular Biology, Oncology and Surgery. According to data from OpenAlex, Lynn Vitale‐Cross has authored 22 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 9 papers in Oncology and 4 papers in Surgery. Recurrent topics in Lynn Vitale‐Cross's work include PI3K/AKT/mTOR signaling in cancer (5 papers), Cancer-related Molecular Pathways (5 papers) and Mesenchymal stem cell research (4 papers). Lynn Vitale‐Cross is often cited by papers focused on PI3K/AKT/mTOR signaling in cancer (5 papers), Cancer-related Molecular Pathways (5 papers) and Mesenchymal stem cell research (4 papers). Lynn Vitale‐Cross collaborates with scholars based in United States, Hungary and Australia. Lynn Vitale‐Cross's co-authors include J. Silvio Gutkind, Alfredo Molinolo, Daniel Martı́n, Panomwat Amornphimoltham, Sandra Oršulić, Yi Li, Harold Varmus, Robert A. Soslow, Matthew P. Hoffman and Sarah M. Knox and has published in prestigious journals such as Science, Nature Communications and Journal of Clinical Oncology.

In The Last Decade

Lynn Vitale‐Cross

22 papers receiving 1.5k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Lynn Vitale‐Cross 824 537 276 212 174 22 1.5k
Jene Choi 1.4k 1.7× 762 1.4× 339 1.2× 179 0.8× 123 0.7× 49 2.2k
Peter Lembessis 693 0.8× 394 0.7× 282 1.0× 248 1.2× 115 0.7× 63 1.5k
Stefan Siwko 1.2k 1.4× 696 1.3× 286 1.0× 172 0.8× 242 1.4× 43 1.8k
Matthew J. Grimshaw 602 0.7× 469 0.9× 432 1.6× 153 0.7× 361 2.1× 21 1.6k
Mohammad Ghazizadeh 803 1.0× 258 0.5× 172 0.6× 280 1.3× 375 2.2× 104 2.0k
Karl X. Chai 796 1.0× 270 0.5× 278 1.0× 218 1.0× 253 1.5× 48 1.6k
Ryoko Shimizu‐Hirota 544 0.7× 328 0.6× 312 1.1× 365 1.7× 372 2.1× 35 1.8k
Dalit Barkan 759 0.9× 904 1.7× 444 1.6× 161 0.8× 311 1.8× 26 1.9k
Carmen Ardeleanu 401 0.5× 277 0.5× 144 0.5× 180 0.8× 185 1.1× 66 1.3k
Qiaohong Wang 880 1.1× 699 1.3× 157 0.6× 343 1.6× 286 1.6× 33 1.9k

Countries citing papers authored by Lynn Vitale‐Cross

Since Specialization
Citations

This map shows the geographic impact of Lynn Vitale‐Cross's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lynn Vitale‐Cross with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lynn Vitale‐Cross more than expected).

Fields of papers citing papers by Lynn Vitale‐Cross

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lynn Vitale‐Cross. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lynn Vitale‐Cross. The network helps show where Lynn Vitale‐Cross may publish in the future.

Co-authorship network of co-authors of Lynn Vitale‐Cross

This figure shows the co-authorship network connecting the top 25 collaborators of Lynn Vitale‐Cross. A scholar is included among the top collaborators of Lynn Vitale‐Cross based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lynn Vitale‐Cross. Lynn Vitale‐Cross is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mayer, Balázs, Lynn Vitale‐Cross, Vamsee D. Myneni, et al.. (2024). Bone marrow stromal cell-derived hepcidin has antimicrobial and immunomodulatory activities. Scientific Reports. 14(1). 3986–3986. 4 indexed citations
2.
Ren, Jiaqiang, Lynn Vitale‐Cross, David F. Stroncek, et al.. (2023). The Potential Use of THP-1, a Monocytic Leukemia Cell Line, to Predict Immune-Suppressive Potency of Human Bone-Marrow Stromal Cells (BMSCs) In Vitro: A Pilot Study. International Journal of Molecular Sciences. 24(17). 13258–13258. 4 indexed citations
3.
Vitale‐Cross, Lynn, et al.. (2022). SARS-CoV-2 entry sites are present in all structural elements of the human glossopharyngeal and vagal nerves: Clinical implications. EBioMedicine. 78. 103981–103981. 27 indexed citations
4.
Németh, Krisztián, Sandra D. MacDonald, Mehrnoosh Abshari, et al.. (2020). Bone Marrow-Derived Mesenchymal Stromal Cells (MSCs) Modulate the Inflammatory Character of Alveolar Macrophages from Sarcoidosis Patients. Journal of Clinical Medicine. 9(1). 278–278. 11 indexed citations
5.
Wang, Zhiyong, Xiaodong Feng, Alfredo Molinolo, et al.. (2019). 4E-BP1 Is a Tumor Suppressor Protein Reactivated by mTOR Inhibition in Head and Neck Cancer. Cancer Research. 79(7). 1438–1450. 54 indexed citations
6.
Wang, Zhiyong, Victoria H. Wu, Michael M. Allevato, et al.. (2019). Syngeneic animal models of tobacco-associated oral cancer reveal the activity of in situ anti-CTLA-4. Nature Communications. 10(1). 5546–5546. 119 indexed citations
7.
Day, Terry A., Keisuke Shirai, Paul E. O’Brien, et al.. (2018). Inhibition of mTOR Signaling and Clinical Activity of Rapamycin in Head and Neck Cancer in a Window of Opportunity Trial. Clinical Cancer Research. 25(4). 1156–1164. 67 indexed citations
8.
Myneni, Vamsee D., Daniel Martı́n, Lynn Vitale‐Cross, et al.. (2018). Mesenchymal stromal cells from infants with simple polydactyly modulate immune responses more efficiently than adult mesenchymal stromal cells. Cytotherapy. 21(2). 148–161. 9 indexed citations
9.
Vitale‐Cross, Lynn, Balázs Mayer, Vamsee D. Myneni, et al.. (2018). Immunogenic potential of human bone marrow mesenchymal stromal cells is enhanced by hyperthermia. Cytotherapy. 20(12). 1437–1444. 15 indexed citations
10.
Porat‐Shliom, Natalie, Amber Jean Tietgens, Christina M. Van Itallie, et al.. (2016). Liver kinase B1 regulates hepatocellular tight junction distribution and function in vivo. Hepatology. 64(4). 1317–1329. 39 indexed citations
11.
Vitale‐Cross, Lynn, Daniel Martı́n, Abraham Schneider, et al.. (2015). Prevention of Tumor Growth Driven by PIK3CA and HPV Oncogenes by Targeting mTOR Signaling with Metformin in Oral Squamous Carcinomas Expressing OCT3. Cancer Prevention Research. 8(3). 197–207. 48 indexed citations
12.
Shirai, Keisuke, Terry A. Day, Éva Szabó, et al.. (2015). A pilot, single arm, prospective trial using neoadjuvant rapamycin prior to definitive therapy in head and neck squamous cell carcinoma.. Journal of Clinical Oncology. 33(15_suppl). 6071–6071. 7 indexed citations
13.
Wang, Zhiyong, Daniel Martı́n, Alfredo Molinolo, et al.. (2014). mTOR Co-Targeting in Cetuximab Resistance in Head and Neck Cancers Harboring PIK3CA and RAS Mutations. JNCI Journal of the National Cancer Institute. 106(9). 89 indexed citations
14.
Homolya, László, Dong Fu, Prabuddha Sengupta, et al.. (2014). LKB1/AMPK and PKA Control ABCB11 Trafficking and Polarization in Hepatocytes. PLoS ONE. 9(3). e91921–e91921. 37 indexed citations
15.
Martı́n, Daniel, Martı́n C. Abba, Alfredo Molinolo, et al.. (2014). The head and neck cancer cell oncogenome: a platform for the development of precision molecular therapies. Oncotarget. 5(19). 8906–8923. 154 indexed citations
16.
Vitale‐Cross, Lynn, Alfredo Molinolo, Daniel Martı́n, et al.. (2012). Metformin Prevents the Development of Oral Squamous Cell Carcinomas from Carcinogen-Induced Premalignant Lesions. Cancer Prevention Research. 5(4). 562–573. 106 indexed citations
17.
Knox, Sarah M., Isabelle M.A. Lombaert, Xylena Reed, et al.. (2010). Parasympathetic Innervation Maintains Epithelial Progenitor Cells During Salivary Organogenesis. Science. 329(5999). 1645–1647. 248 indexed citations
18.
Raimondi, Ana R., Lynn Vitale‐Cross, Panomwat Amornphimoltham, J. Silvio Gutkind, & Alfredo Molinolo. (2006). Rapid Development of Salivary Gland Carcinomas upon Conditional Expression of K-ras Driven by the Cytokeratin 5 Promoter. American Journal Of Pathology. 168(5). 1654–1665. 28 indexed citations
19.
Oršulić, Sandra, Yi Li, Robert A. Soslow, et al.. (2002). Induction of ovarian cancer by defined multiple genetic changes in a mouse model system. Cancer Cell. 1(1). 53–62. 278 indexed citations
20.
Gutkind, J. Silvio & Lynn Vitale‐Cross. (1996). The pathway linking small GTP-binding proteins of the Rho family to cytoskeletal components and novel signaling kinase cascades. Seminars in Cell and Developmental Biology. 7(5). 683–690. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jene Choi Breakdown of academic impact, for papers by Peter Lembessis Breakdown of academic impact, for papers by Stefan Siwko Breakdown of academic impact, for papers by Matthew J. Grimshaw Breakdown of academic impact, for papers by Mohammad Ghazizadeh Breakdown of academic impact, for papers by Karl X. Chai Breakdown of academic impact, for papers by Ryoko Shimizu‐Hirota Breakdown of academic impact, for papers by Dalit Barkan Breakdown of academic impact, for papers by Carmen Ardeleanu Breakdown of academic impact, for papers by Qiaohong Wang
Rankless by CCL
2026